Dr. Marc Cluzel - Net Worth and Insider Trading
Dr. Marc Cluzel Net Worth
The estimated net worth of Dr. Marc Cluzel is at least $0 dollars as of 2025-07-22. Dr. Marc Cluzel is the Supervisory Board of MorphoSys AG and owns about 0 shares of MorphoSys AG (XTER:MOR) stock worth over $0. Details can be seen in Dr. Marc Cluzel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dr. Marc Cluzel has not made any transactions after 2023-09-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dr. Marc Cluzel
Dr. Marc Cluzel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dr. Marc Cluzel owns 1 companies in total, including MorphoSys AG (XTER:MOR) .
Click here to see the complete history of Dr. Marc Cluzel’s form 4 insider trades.
Insider Ownership Summary of Dr. Marc Cluzel
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| XTER:MOR | MorphoSys AG | 2023-09-18 | Supervisory Board |
Dr. Marc Cluzel Latest Holdings Summary
Dr. Marc Cluzel currently owns a total of 1 stock. Dr. Marc Cluzel owns 0 shares of MorphoSys AG (XTER:MOR) as of September 18, 2023, with a value of $0.
Latest Holdings of Dr. Marc Cluzel
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XTER:MOR | MorphoSys AG | 2023-09-18 | 0 | 67.25 | 0 |
Holding Weightings of Dr. Marc Cluzel
Dr. Marc Cluzel Form 4 Trading Tracker
According to the SEC Form 4 filings, Dr. Marc Cluzel has made a total of 7 transactions in MorphoSys AG (XTER:MOR) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in MorphoSys AG is the acquisition of 25 shares on September 18, 2023, which cost Dr. Marc Cluzel around $775.
Insider Trading History of Dr. Marc Cluzel
- 1
Dr. Marc Cluzel Trading Performance
GuruFocus tracks the stock performance after each of Dr. Marc Cluzel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dr. Marc Cluzel is 8.59%. GuruFocus also compares Dr. Marc Cluzel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dr. Marc Cluzel within 3 months outperforms 5 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dr. Marc Cluzel's insider trading performs compared to the benchmark.
Performance of Dr. Marc Cluzel
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.42 | | | | | |
| Relative Return to S&P 500(%) | -0.71 | | | | | |
Dr. Marc Cluzel Ownership Network
Ownership Network List of Dr. Marc Cluzel
Ownership Network Relation of Dr. Marc Cluzel
Dr. Marc Cluzel Owned Company Details
What does MorphoSys AG do?
Who are the key executives at MorphoSys AG?
Dr. Marc Cluzel is the Supervisory Board of MorphoSys AG. Other key executives at MorphoSys AG include and Supervisory Board Krisja Vermeylen .
MorphoSys AG (XTER:MOR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of MorphoSys AG (XTER:MOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MorphoSys AG (XTER:MOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
MorphoSys AG (XTER:MOR)'s detailed insider trading history can be found in Insider Trading Tracker table.
MorphoSys AG Insider Transactions
Dr. Marc Cluzel Mailing Address
Above is the net worth, insider trading, and ownership report for Dr. Marc Cluzel. Currently GuruFocus does not have mailing address information for Dr. Marc Cluzel.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
